We are live on ! Find out more
Name Net increased
positions
Increased positions Reduced positions Return since
31 Mar ‘23
LESL icon
1
Leslie's
LESL
$9.83M
50 117 67 99.5%
DH icon
2
Definitive Healthcare
DH
$74.6M
36 69 33 93.2%
TTEC icon
3
TTEC Holdings
TTEC
$119M
36 94 58 93.4%
NFE icon
4
New Fortress Energy
NFE
$94.3M
34 98 64 98.9%
EAF icon
5
GrafTech
EAF
$200M
33 85 52 84.2%
DOMO icon
6
Domo
DOMO
$177M
32 64 32 73.5%
FLNA
7
Filana Therapeutics
FLNA
$42.7M
30 58 28 96.3%
STEM icon
8
Stem
STEM
$47.7M
30 89 59 95.3%
FULC icon
9
Fulcrum Therapeutics
FULC
$248M
29 51 22 30.5%
BLNK icon
10
Blink Charging
BLNK
$74.1M
29 70 41 94%
PLRX icon
11
Pliant Therapeutics
PLRX
$66.3M
27 57 30 96%
MED icon
12
Medifast
MED
$108M
27 107 80 90.6%
INGN icon
13
Inogen
INGN
$174M
26 63 37 48.6%
OTLK icon
14
Outlook Therapeutics
OTLK
$169M
26 34 8 95.9%
DXLG icon
15
Destination XL Group
DXLG
$34.3M
25 59 34 88.7%
CHPT icon
16
ChargePoint
CHPT
$138M
25 127 102 97.4%
LUNG icon
17
Pulmonx
LUNG
$52.8M
24 47 23 88.8%
UPLD icon
18
Upland Software
UPLD
$14.4M
24 53 29 88.6%
BMEA icon
19
Biomea Fusion
BMEA
$90.4M
24 31 7 96%
PRPL icon
20
Purple Innovation
PRPL
$35.7M
23 45 22 87.6%
MXCT icon
21
MaxCyte
MXCT
$112M
23 51 28 78.8%
ORBS
22
Eightco Holdings
ORBS
$232M
22 24 2 97.1%
DAVA icon
23
Endava
DAVA
$153M
22 76 54 95.7%
OWLT icon
24
Owlet
OWLT
$150M
22 26 4 13.9%
KPTI icon
25
Karyopharm Therapeutics
KPTI
$161M
22 52 30 87.8%